Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

MDEV vs NVIR: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NVIR Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 1–2 Matrix Metrics)

NVIR Overall Winner 6-Pillar Tally: MDEV 0 – 0 NVIR (6 Tie) Matrix Metrics: MDEV 2 – 1 NVIR

As of Nov 16, 2026, Horizon Kinetics Energy and Remediation ETF (NVIR) is the stronger overall head-to-head candidate over First Trust Indxx Medical Devices ETF (MDEV) in the Tradestie Institutional Equity Comparison Engine, winning 1–2 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). MDEV carries a Unified Composite Score of 41.2/100 (SELL) at $22.56 (N/M Forward P/E, N/A operating margin), whereas NVIR carries 48.2/100 (HOLD) at $39.22 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: MDEV trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 57.5); meanwhile NVIR is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 48.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About MDEV vs NVIR
MDEV Cboe BZX
First Trust Indxx Medical Devices ETF
Institutional Equity
$22.56
-0.33% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.55β · 25% Vol
Unified Composite Score
41.2 / 100 SELL
Tech 31.0 Fund 43.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (1.8% over 20 days), RSI 57
RSI-14: 57.5 · SMA20: $22.34 · SMA50: $21.35
NVIR NYSE Arca Head-to-Head Winner
Horizon Kinetics Energy and Remediation ETF
Institutional Equity
$39.22
+0.32% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.12β · 27% Vol
Unified Composite Score
48.2 / 100 HOLD
Tech 51.0 Fund 50.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -0.6%) with fading momentum, RSI 49
RSI-14: 48.7 · SMA20: $39.64 · SMA50: $39.55

6-Pillar Scorecard Institutional Category Breakdown (MDEV 0 – 0 NVIR)

Columns: Metric · MDEV · NVIR
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Distribution
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: MDEV (2) vs NVIR (1)
Institutional Metric MDEV NVIR Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
86% ($18–$23) 78% ($32–$41) Stronger Trend MDEV
Beta / 30D Volatility
Risk Regime
0.55β · 25% Vol 0.12β · 27% Vol Lower Realized Risk MDEV
Unified Institutional Score
Composite Signal
41.2 / 100 (SELL) 48.2 / 100 (HOLD) Higher Composite NVIR
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon MDEV +5.67 pp
MDEV: +5.2% · NVIR: -0.47%
3M Horizon MDEV +8.62 pp
MDEV: +5.53% · NVIR: -3.09%
6M Horizon MDEV +26.77 pp
MDEV: +25.44% · NVIR: -1.33%
1Y Horizon NVIR +10.33 pp
MDEV: +11.09% · NVIR: +21.42%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MDEV vs NVIR. Trailing 12-month operating profitability (MDEV N/A vs NVIR N/A) and valuation multiples (MDEV N/M vs NVIR N/M Forward P/E) are benchmarked directly in Pillar 4 below.

MDEV ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
NVIR ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
MDEV UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MDEV Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
NVIR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NVIR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
MDEV Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
NVIR Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ MDEV vs NVIR Key Questions & Quantitative Answers

As of Nov 16, 2026, Horizon Kinetics Energy and Remediation ETF (NVIR) is the stronger overall head-to-head candidate over First Trust Indxx Medical Devices ETF (MDEV) in the Tradestie Institutional Equity Comparison Engine, winning 1–2 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). MDEV carries a Unified Composite Score of 41.2/100 (SELL) at $22.56 (N/M Forward P/E, N/A operating margin), whereas NVIR carries 48.2/100 (HOLD) at $39.22 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: MDEV trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 57.5); meanwhile NVIR is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 48.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

MDEV and NVIR split Growth & Scale metrics: MDEV posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with NVIR at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, MDEV generates N/A in USD-normalized revenue versus N/A for NVIR. In operating R&D and SG&A reinvestment, MDEV deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for NVIR.

MDEV and NVIR trade at balanced relative valuation multiples. MDEV trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas NVIR trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MDEV (N/A ROE) versus NVIR (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, MDEV carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.55β · 25% Vol realized risk). By comparison, NVIR carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.12β · 27% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.